Merck global human health president
Executive Summary
GE Healthcare Bio-Sciences CEO Peter Loescher becomes Merck's first global human health president effective May 1. Loescher will oversee the company's sales and marketing divisions - U.S. Human Health, Human Health Asia Pacific, Human Health Intercontinental and Merck Vaccines - which previously reported directly to CEO Richard Clark. The global human health president position, created as part of the company's sales restructuring announced in December, is intended to produce greater continuity for customers across different markets (1"The Pink Sheet" Dec. 19, 2005, p. 3)...
You may also be interested in...
Merck Sales Restructuring Sacrifices Physician Detailing To Payer Marketing
Merck's restructuring program is shifting selling and marketing resources away from physician detailing towards payer and patient promotion, CEO Richard Clark indicated during the firm's annual business review in Whitehouse Station, N.J
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.